Basics Tango Therapeutics, Inc. IPO Date: September 3, 2020 Sector: Healthcare Industry: Biotech Market Cap: $640.61M Activated in VL: True Average Daily Range Avg Daily Range: $0.24 | 3.84% Avg Daily Range (30 D): $0.18 | 3.31% Avg Daily Range (90 D): $0.15 | 6.03% Institutional Daily Volume Avg Daily Volume: .67M Avg Daily Volume (30 D): 2.04M Avg Daily Volume (90 D): 1.93M Trade Size Avg Trade Size (Sh.): 111 Avg Trade Size (Sh.) (30 D): 119 Avg Trade Size (Sh.) (90 D): 146 Institutional Trades Total Inst.Trades: 558 Avg Inst. Trade: $1.63M Avg Inst. Trade (30 D): $1.89M Avg Inst. Trade (90 D): $1.77M Avg Inst. Trade Volume: .23M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.52M Avg Closing Trade (30 D): $1.67M Avg Closing Trade (90 D): $1.62M Avg Closing Volume: 205.15K     News Jun 27, 2025 @ 11:00 AM Tango Therapeutics Announces First Patient Dosed i... Source: Tango Therapeutics May 27, 2025 @ 11:00 AM Tango Therapeutics to Participate in the 46th Annu... Source: N/A May 12, 2025 @ 11:00 AM Tango Therapeutics Reports First Quarter 2025 Fina... Source: N/A Apr 9, 2025 @ 9:00 AM Barbara Weber, M.D., Elected to ITM Supervisory Bo... Source: N/A Jun 14, 2024 @ 9:10 AM Tango Therapeutics (TNGX) Moves 10.3% Higher: Will... Source: Zacks Equity Research Financials   TTM Q4 2024 FY 2024 Basic EPS $-.36 $-.34 $-1.19 Diluted EPS $-.36 $-.34 $-1.19 Revenue $ 5.39M $ 4.12M $ 42.07M Gross Profit $ $ $ Net Income / Loss $ -39.88M $ -37.67M $ -130.3M Operating Income / Loss $ -42.53M $ -40.91M $ -145.6M Cost of Revenue $ $ $ Net Cash Flow $ -11.1M $ 16.38M $ 2.29M PE Ratio